Doorgaan naar hoofdcontent

Ronapreve - opinion on variation to marketing authorisation | European Medicines Agency (EMA)

Ronapreve - opinion on variation to marketing authorisation | European Medicines Agency (EMA)

On 30 January 2025, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending a change to the terms of the marketing authorisation for the medicinal product Ronapreve. The marketing authorisation holder for th

Lees verder »
Wil je het laatste nieuws in jouw mailbox? Meld je dan aan voor de nieuwsbrief